| Overview |
| bsm-52156r-apc-cy7-100ul |
| FOXO3a (Ser253) Monoclonal Antibody, APC-Cy7 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| APC-Cy7 |
| Rabbit |
| Synthetic peptide derived from human FOXO3a(S253), around 230-280aa (phospho S253). |
| S253 |
| Monoclonal |
| 25B3 |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 2309 |
| O43524 |
| FOXO2; AF6q21; FKHRL1; FOXO3A; FKHRL1P2; Forkhead box protein O3; AF6q21 protein; Forkhead in rhabdomyosarcoma-like 1; FOXO3 |
| Transcriptional activator which triggers apoptosis in the absence of survival factors, including neuronal cell death upon oxidative stress. Recognizes and binds to the DNA sequence 5'-[AG]TAAA[TC]A-3'. Participates in post-transcriptional regulation of MYC: following phosphorylation by MAPKAPK5, promotes induction of miR-34b and miR-34c expression, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent its translation. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz